Care for Substance Dependent Pregnant Women - PowerPoint PPT Presentation

1 / 24
About This Presentation
Title:

Care for Substance Dependent Pregnant Women

Description:

Care for Substance Dependent Pregnant Women & Parents of Neonates. The Women's Alcohol & Drug Service, The Royal Women's Hospital. Pregnant substance using women ... – PowerPoint PPT presentation

Number of Views:30
Avg rating:3.0/5.0
Slides: 25
Provided by: WCH86
Category:

less

Transcript and Presenter's Notes

Title: Care for Substance Dependent Pregnant Women


1
Care for Substance Dependent Pregnant Women
Parents of Neonates
  • The Womens Alcohol Drug Service, The Royal
    Womens Hospital

2
Pregnant substance using women
  • Pregnancy at high risk of complications
  • High risk environment
  • Range of additional psychosocial stressors
  • Increased likelihood of child abuse neglect

3
Profile of WADS clients
  • Age 18-44
  • Self referral, AOD treatment
  • Aboriginal 6
  • North West metro, southern
  • Not married
  • Previous children

4
Profile of the women
  • Multiple drug use
  • IV drug related issues Hepatitis, HIV
  • Poor diet
  • Poor oral health
  • Financial disadvantage
  • Housing instability
  • Homelessness
  • Past/ present violence
  • Sexual assault
  • Relationship issues
  • Sole parenting
  • Negative childhood experiences
  • Subordinate position
  • Legal issues

5
Housing 05/06WADS Clients
  • At time of initial assessment 33 homeless
  • 56 remained in same postcode
  • 44 moved postcode
  • 34 moved region

6
Mental health issues
  • Dual diagnosis
  • Depression/ anxiety
  • Self-mutilation
  • Suicide attempts
  • Low self esteem
  • Eating disorders
  • Psychological distress
  • Self medication

7
Vulnerable women
  • Drug saturated social environment
  • Clients of child protection systems
  • Perpetrators or victims of crime
  • Educational disadvantage
  • Poor employment opportunities
  • Intergenerational substance use
  • Separation from own family
  • Inaccessible service systems

8
Prevalence
  • Prevalence of DA use in pregnancy unknown in
    Australia
  • No reliable system of recording/data collection
    Privacy/ confidentiality issues
  • Private obstetric care not included
  • Undisclosed DA use

9
Primary Drug use 05/06WADS clients
  • Heroin
  • Methadone
  • Cannabis
  • Alcohol
  • Buprenorphine
  • Amphetamines
  • Benzodiazepines

10
Sequelae of DA use in pregnancy
  • Medical and social support availability
  • Increased risk of SIDS
  • Poor obstetric, fetal and neonatal outcomes
  • Economic social cost
  • Difficulties with mother-infant attachment
  • Child behavioral developmental issues
  • Parental coping ability

11
Role of pregnancy care
  • Established association between pregnancy care
    and improved birth outcomes
  • Maternal neonatal outcomes compare favourably
    with non-exposed infants when specialist DA
    obstetric services provided
  • Care based on principles of harm minimization

12
window of opportunity
  • Pregnancy is a time when substance using women
    become visible to service providers
  • Imperative to engage women as early as possible
    in pregnancy care

13
Early engagement
  • All pregnant women screened for DA use
  • Pregnancy advice and genetic counseling
  • Options for care discussed with women
  • Assessment of needs early and ongoing
  • Pregnancy care discharge planning

14
Early engagement
  • Referrals for mental health issues
  • Referrals for partner DA, mental health
    counseling
  • Start to address DA and lifestyle issues
  • Initiate pharmacotherapy
  • Relapse prevention
  • Limit reliance on advice from informal networks

15
Late initiation for care
  • Substance using women are typically low users of
    obstetric services
  • Many present at a late stage in pregnancy
  • Unaware of pregnancy due to menstrual
    irregularity
  • Pregnancy unplanned
  • Ambivalence toward pregnancy
  • Interventions often crisis driven

16
Barriers to disclosure engaging in care
  • Guilt and shame
  • Past negative experiences
  • Access issues
  • Unsuitable appointment times
  • Discouraging information from drug-using networks
  • Mobile lifestyle

17
Research 2005- Womens Voices
  • Fear of child protection
  • Fear of judgmental attitudes of health
    professionals
  • Lack of stable housing
  • Unaware of pregnancy
  • Lost opportunity or lifeline?, MC Tobin

18
Range of needs
  • Not all substance using pregnant woman have
    complex DA and psychosocial needs.
  • Provide less intensive pregnancy care
  • Some are stable on pharmacotherapy, do not
    present as such high risk, however their DA
    status requires review throughout pregnancy and
    in the vulnerable early parenting period.

19
Appropriate client information
  • Additional to childbirth education and parenting
    information, women need to be prepared for
  • longer postnatal hospital stays
  • pharmacotherapy management
  • infant withdrawal assessment and management
  • breastfeeding safe infant sleeping

20
Child protection issues
  • Who is the client? Woman or fetus/baby
  • Fear of CP a deterrent to attending for care
  • Challenge of mandatory reporting vs therapeutic
    relationship
  • CP involvement seen as punitive
  • May also see ChildFIRST as CP
  • Pre birth reporting

21
Community referrals
  • Communication gaps between pregnancy and
    community providers identified in infant death
    reviews
  • Develop verbal and written communication
    processes
  • Resource providers with contact details inc.
    phone numbers for feedback/emergencies

22
Issues for providers
  • Multidisciplinary care
  • Non compliance with care referrals
  • Capacity to provide assertive outreach
  • Time required for communications
  • Limited support services
  • Workforce development issues
  • Clients as patients in a maternity hospital
    setting

23
Issues for women
  • Access to specialist services, obstetric and DA
  • Access to pharmacotherapy
  • Fear of disclosure/stigma
  • Guilt, especially if baby withdraws
  • Attitudes of providers

24
Issues for women
  • Child protection issues
  • Economic and lifestyle cost of pharmacotherapy
  • Short term nature of many support services
  • Multiple providers involved in care
  • Special needs of indigenous women
Write a Comment
User Comments (0)
About PowerShow.com